Risk factors
Neogenomics (NEO) risk factors
Item 1A of every Neogenomics Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors41 risks11 new7 dropped14 reworded
Neogenomics faces new operational risks from implementing a Laboratory Information Management System and adopting artificial intelligence technologies. Supply chain dependencies, international trade tariffs, and clinical trial liabilities threaten financial and operating results. The company highlights risks related to convertible notes and intellectual property protection.
Filed Feb 17, 2026 - FY2024 10-K risk factors37 risks
Neogenomics faces intense competition in genetic and molecular testing from established laboratories like Quest and LabCorp.
Filed Feb 18, 2025